Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER
Not Applicable
Active, not recruiting
- Conditions
- CoV2 Positive Caregivers
- Interventions
- Diagnostic Test: Serological tests will be applied on patients blood sampling
- Registration Number
- NCT04341142
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Covid-SER is a prospective multi-center study for the evaluation of diagnostic performance of available serological tests
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 550
Inclusion Criteria
- Seropositive caregivers screened for anti-SARS CoV2 antibodies during their consultation at the occupational medicine of HCL.
- Age: ≥ 18 years old
- Persons having given their written consent and accepting a follow-up every 6 months for 24 months, followed by a final visit at 36 months.
- Persons affiliated to a social security scheme or beneficiary of such a scheme.
Read More
Exclusion Criteria
- Pregnant or lactating woman
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Serological tests will be applied on patients blood sampling Serological tests will be applied on patients blood sampling Serological tests will be applied on patients blood sampling
- Primary Outcome Measures
Name Time Method The positivity (Yes/No) of the serological test. Day 42 The sensitivity and specificity of serological tests (positive or negative) compared to molecular detection of the virus by PCR
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hôpital Lyon Sud,Sainte Eugénie bat 4M,5, Chemin du Grand Revoyet
🇫🇷Pierre-Bénite cedex, France